tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Genmab raises 2025 sales outlook to $3.5B-$3.7B from $3.34B-$3.66B

Raises 2025 operating profit outlook to $1.055B-$1.405B from $895M-$1.365B. The company said, “The improved guidance is driven by higher total royalty revenues from DARZALEX.”

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1